← Back to Search

Communication Strategies for COVID-19 Vaccination

N/A

Waitlist Available

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Has never received a dose of COVID-19 vaccination

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 8 weeks

Awards & highlights

Study Summary

This trial is testing two different ways to communicate about vaccines in order to find the most effective way to increase vaccine rates.

Who is the study for?

This trial is for unvaccinated students, staff, and their household members in participating school districts or residents of St. Louis City/County who are eligible for a COVID-19 vaccine according to CDC guidelines but have not yet received any doses.Check my eligibility

What is being tested?

The study aims to compare two strategies to increase COVID-19 vaccination rates: one involves sending SMS messages with a website link, and the other involves phone calls with peers.See study design

What are the potential side effects?

Since this trial tests communication strategies rather than medical treatments, there are no direct side effects from interventions like drugs or vaccines. However, participants may experience inconvenience or time commitment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have never received a COVID-19 vaccine.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Vaccine Uptake

Secondary outcome measures

Vaccination with Full Dose

Trial Design

2Treatment groups

Active Control

Group I: Phone Call with PeerActive Control1 Intervention

The participant's peer will be a study team member who has the same or similar racial demographic as the participant. All team members conducting the peer phone calls will be trained in motivational interviewing. The participant will be called by their peer via zoom or phone. Motivational interviewing techniques will be utilized with the participant to promote vaccine uptake. The team member will use a facilitator guide throughout the peer intervention.

Group II: Short Message Service (SMS) with an associated link to a multi-media websiteActive Control1 Intervention

The participant will receive a SMS with a brief message containing the following: (1) statement encouraging them to get vaccinated and (2) a link to a multi-media page with videos and additional resources encouraging individuals to be vaccinated. The multi-media website will be housed in the Safe Return To School website and updated by a designated study team members. This page will include the following COVID-19-related resources: publicly available vaccine promotion videos, videos consisting of community members discussing vaccine topics, resources regarding local vaccine sites, and links to additional literature resources.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor

1,933 Previous Clinical Trials

2,293,625 Total Patients Enrolled

26 Trials studying COVID-19

14,164 Patients Enrolled for COVID-19

Media Library

Phone Call with Peer Clinical Trial Eligibility Overview. Trial Name: NCT05419232 — N/A

COVID-19 Research Study Groups: Phone Call with Peer, Short Message Service (SMS) with an associated link to a multi-media website

COVID-19 Clinical Trial 2023: Phone Call with Peer Highlights & Side Effects. Trial Name: NCT05419232 — N/A

Phone Call with Peer 2023 Treatment Timeline for Medical Study. Trial Name: NCT05419232 — N/A

COVID-19 Patient Testimony for trial: Trial Name: NCT05419232 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently enrolled in the trial?

"Affirmative. According to clinicaltrials.gov, this study is currently accepting applications from potential candidates. The trial was initially posted on July 15th 2022 and the most recent update came on August 22nd of that year. 6100 people need to be recruited across 7 sites for full enrolment into the experiment."

Answered by AI

How many geographical areas are hosting this research project?

"7 locations are participating in this research project, including Jennings School District in Jennings, Ferguson-Florissant School District in Hazelwood, and Pattonville School District in Saint Ann."

Answered by AI

Are there any openings at this moment for those interested in participating in the trial?

"That is accurate. Per information available on clinicaltrials.gov, this study has been initiated and is looking for 6100 participants from 7 different locations. The trial was initially announced on July 15th 2022, with the last edit being made August 22nd of that same year."

Answered by AI